| Engineering live cell surfaces with functional polymers via cytocompatible controlled radical polymerization J Niu, DJ Lunn, A Pusuluri, JI Yoo, MA O'Malley, S Mitragotri, HT Soh, ... Nature Chemistry 9 (6), 537-545, 2017 | 374 | 2017 |
| Cellular backpacks for macrophage immunotherapy CW Shields IV, MA Evans, LLW Wang, N Baugh, S Iyer, D Wu, Z Zhao, ... Science Advances 6 (18), eaaz6579, 2020 | 283 | 2020 |
| Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions A Da Silva-Candal, T Brown, V Krishnan, I Lopez-Loureiro, ... Journal of Controlled Release 309, 94-105, 2019 | 123 | 2019 |
| A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer DR Vogus, MA Evans, A Pusuluri, A Barajas, M Zhang, V Krishnan, ... Journal of Controlled Release 267, 191-202, 2017 | 92 | 2017 |
| DAFODIL: a novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy KM Camacho, S Menegatti, DR Vogus, A Pusuluri, Z Fuchs, M Jarvis, ... Journal of Controlled Release 229, 154-162, 2016 | 66 | 2016 |
| Treating tumors at low drug doses using an aptamer–peptide synergistic drug conjugate A Pusuluri, V Krishnan, V Lensch, A Sarode, E Bunyan, DR Vogus, ... Angewandte Chemie International Edition 58 (5), 1437-1441, 2019 | 56 | 2019 |
| Click-particle display for base-modified aptamer discovery CKL Gordon, D Wu, A Pusuluri, TA Feagin, AT Csordas, MS Eisenstein, ... ACS chemical biology 14 (12), 2652-2662, 2019 | 51 | 2019 |
| Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments A Pusuluri, D Wu, S Mitragotri Journal of Controlled Release 305, 130-154, 2019 | 51 | 2019 |
| Design principles of drug combinations for chemotherapy D Wu, A Pusuluri, D Vogus, V Krishnan, CW Shields IV, J Kim, A Razmi, ... Journal of controlled release 323, 36-46, 2020 | 40 | 2020 |
| Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin A Pusuluri, V Krishnan, D Wu, CW Shields IV, LW Wang, S Mitragotri Bioengineering & Translational Medicine 4 (2), e10129, 2019 | 33 | 2019 |
| Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro‐in vivo correlation DR Vogus, A Pusuluri, R Chen, S Mitragotri Bioengineering & Translational Medicine 3 (1), 49-57, 2018 | 32 | 2018 |
| Hyaluronic acid conjugates for topical treatment of skin cancer lesions V Krishnan, K Peng, A Sarode, S Prakash, Z Zhao, SK Filippov, ... Science Advances 7 (24), eabe6627, 2021 | 19 | 2021 |
| O, Malley, MA; Mitragotri, S.; Soh, HT; Hawker, CJ Engineering live cell surfaces with functional polymers via cytocompatible controlled radical polymerization J Niu, DJ Lunn, A Pusuluri, JI Yoo Nat. Chem 9 (6), 537-545, 2017 | 11 | 2017 |
| Selective Chemical Modification of DNA with Boronic Acids by On-Column CuAAc Reactions M Debiais, JJ Vasseur, S Müller, M Smietana Synthesis 52 (20), 2962-2969, 2020 | 8 | 2020 |
| Optimized 5-fluorouridine prodrug for co-loading with doxorubicin in clinically relevant liposomes D Wu, D Vogus, V Krishnan, M Broto, A Pusuluri, Z Zhao, N Kapate, ... Pharmaceutics 13 (1), 107, 2021 | 4 | 2021 |
| Click-PD: A quantitative method for base-modified aptamer discovery CKL Gordon, D Wu, TA Feagin, A Pusuluri, AT Csordas, M Eisenstein, ... bioRxiv, 626572, 2019 | 2 | 2019 |
| Aptamer-peptide-drug conjugates: Targeted delivery of synergistic drug combinations with ratiometric precision A Pusuluri, S Menegatti, HT Soh, S Mitragotri ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | 1 | 2017 |
| Controlling Cellular Phenotypes Via Cytokine-Releasing Backpacks for Cancer Immunotherapy CW Shields, MA Evans, LW Wang, S Iyer, D Wu, A Pusuluri, S Mitragotri 2019 AIChE Annual Meeting, 2019 | | 2019 |
| Aptamer targeted delivery of synergistic drug combinations for effective cancer therapy A Pusuluri University of California, Santa Barbara, 2018 | | 2018 |
| Aptamer-Peptide-Drug Conjugates: Delivery of Precise Synergistic Drug Ratios for Enhanced Cancer Selectivity A Pusuluri, S Menegatti, HT Soh, S Mitragotri 2017 AIChE Annual Meeting, 2017 | | 2017 |
Samir MitragotriHarvard University, Wyss Institute, UC Santa Barbara, MIT在 g.harvard.edu 的电子邮件经过验证
